Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308018176> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W4308018176 endingPage "1077" @default.
- W4308018176 startingPage "1071" @default.
- W4308018176 abstract "BackgroundIn locally advanced non-small-cell lung cancer (NSCLC), the addition of chemotherapy to radiotherapy and consolidation with durvalumab leads to a significant increase in overall survival and represents the most profound innovation of the last decade.ObjectivesAnalysis of new possibilities for the state-of-the-art implementation of definitive radiochemotherapy concepts.Materials and methodsEvaluation of prospective and randomised studies regarding improvements in treatment outcomes.ResultsOverall survival benefit of consolidating checkpoint inhibitor therapy after combined radiochemotherapy with durvalumab is 43% (95% confidence interval 38–47%) versus 33% (27–40%) in the placebo group in an updated analysis of the PACIFIC trial for 5‑year survival; stratified hazard ratio for death is 0.72 (95% CI 0.59–0.89, p = 0.0025). In the dose escalation studies, increased pulmonary and oesophageal side effects were observed, so no immediate clinical benefit could be derived from the increase in local efficacy. Improved imaging before and during therapy and optimised possibilities of dose application, especially by using intensity-modulated radiotherapy (IMRT), allow selective sparing of healthy structures, which increases the ability to safely intensify radiotherapy also in connection with new immunomodulatory substance combinations.ConclusionThe integration of immunotherapy, the stringent use of fluorodeoxyglucose positron emission tomography (FDG-PET) in staging and radiation planning, the widespread use of highly conformal radiation techniques (IMRT; volumetric modulated arc therapy, VMAT) and the consistent application of image-guided radiotherapy have led to significant improvements in treatment outcomes." @default.
- W4308018176 created "2022-11-07" @default.
- W4308018176 creator A5011671256 @default.
- W4308018176 creator A5040777787 @default.
- W4308018176 creator A5072753291 @default.
- W4308018176 date "2022-11-03" @default.
- W4308018176 modified "2023-10-18" @default.
- W4308018176 title "Moderne definitive Radiochemotherapie – State of the Art-Umsetzung und neue Konsolidierungsstrategien" @default.
- W4308018176 cites W2019570186 @default.
- W4308018176 cites W2082226281 @default.
- W4308018176 cites W2104701073 @default.
- W4308018176 cites W2164069196 @default.
- W4308018176 cites W2178570731 @default.
- W4308018176 cites W2263280562 @default.
- W4308018176 cites W2287904894 @default.
- W4308018176 cites W2401873646 @default.
- W4308018176 cites W2522150959 @default.
- W4308018176 cites W2528393079 @default.
- W4308018176 cites W2781965877 @default.
- W4308018176 cites W2795351448 @default.
- W4308018176 cites W2893824814 @default.
- W4308018176 cites W2995072671 @default.
- W4308018176 cites W3011596192 @default.
- W4308018176 cites W3087210493 @default.
- W4308018176 cites W3104847433 @default.
- W4308018176 cites W3129152618 @default.
- W4308018176 cites W3133679809 @default.
- W4308018176 cites W3164336527 @default.
- W4308018176 cites W3186004230 @default.
- W4308018176 cites W4211243765 @default.
- W4308018176 cites W4213439205 @default.
- W4308018176 cites W4226175083 @default.
- W4308018176 cites W4281700406 @default.
- W4308018176 cites W4283312679 @default.
- W4308018176 doi "https://doi.org/10.1007/s00761-022-01250-4" @default.
- W4308018176 hasPublicationYear "2022" @default.
- W4308018176 type Work @default.
- W4308018176 citedByCount "0" @default.
- W4308018176 crossrefType "journal-article" @default.
- W4308018176 hasAuthorship W4308018176A5011671256 @default.
- W4308018176 hasAuthorship W4308018176A5040777787 @default.
- W4308018176 hasAuthorship W4308018176A5072753291 @default.
- W4308018176 hasConcept C121608353 @default.
- W4308018176 hasConcept C126322002 @default.
- W4308018176 hasConcept C143998085 @default.
- W4308018176 hasConcept C207103383 @default.
- W4308018176 hasConcept C2776256026 @default.
- W4308018176 hasConcept C2777701055 @default.
- W4308018176 hasConcept C2777742743 @default.
- W4308018176 hasConcept C2780030458 @default.
- W4308018176 hasConcept C2989005 @default.
- W4308018176 hasConcept C44249647 @default.
- W4308018176 hasConcept C509974204 @default.
- W4308018176 hasConcept C71924100 @default.
- W4308018176 hasConceptScore W4308018176C121608353 @default.
- W4308018176 hasConceptScore W4308018176C126322002 @default.
- W4308018176 hasConceptScore W4308018176C143998085 @default.
- W4308018176 hasConceptScore W4308018176C207103383 @default.
- W4308018176 hasConceptScore W4308018176C2776256026 @default.
- W4308018176 hasConceptScore W4308018176C2777701055 @default.
- W4308018176 hasConceptScore W4308018176C2777742743 @default.
- W4308018176 hasConceptScore W4308018176C2780030458 @default.
- W4308018176 hasConceptScore W4308018176C2989005 @default.
- W4308018176 hasConceptScore W4308018176C44249647 @default.
- W4308018176 hasConceptScore W4308018176C509974204 @default.
- W4308018176 hasConceptScore W4308018176C71924100 @default.
- W4308018176 hasIssue "12" @default.
- W4308018176 hasLocation W43080181761 @default.
- W4308018176 hasOpenAccess W4308018176 @default.
- W4308018176 hasPrimaryLocation W43080181761 @default.
- W4308018176 hasRelatedWork W2173168058 @default.
- W4308018176 hasRelatedWork W2213433074 @default.
- W4308018176 hasRelatedWork W2340130805 @default.
- W4308018176 hasRelatedWork W2556093218 @default.
- W4308018176 hasRelatedWork W2601574680 @default.
- W4308018176 hasRelatedWork W2765995209 @default.
- W4308018176 hasRelatedWork W2884191226 @default.
- W4308018176 hasRelatedWork W3115829157 @default.
- W4308018176 hasRelatedWork W3163691534 @default.
- W4308018176 hasRelatedWork W4288434600 @default.
- W4308018176 hasVolume "28" @default.
- W4308018176 isParatext "false" @default.
- W4308018176 isRetracted "false" @default.
- W4308018176 workType "article" @default.